Amgen - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Amgen

Top of Directory » All Categories » by Company » Amgen



  • OTIS Autoimmune Diseases in Pregnancy Project

    Conditions:   Ankylosing Spondylitis;   Psoriatic Arthritis;   Psoriasis;   Rheumatoid Arthritis
    Intervention:  
    Sponsors:   University of California, San Diego;   Organization of Teratology Information Specialists (OTIS);   Amgen
    Recruiting - verified November 2009
  • Panitumumab and Irinotecan for Malignant Gliomas

    Condition:   Recurrent Grade IV Malignant Glioma
    Intervention:   Drug: Panitumumab in Combination with Irinotecan
    Sponsors:   Duke University;   Amgen
    Not yet recruiting - verified November 2009
  • Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma

    Condition:   Malignant Lymphoma
    Interventions:   Drug: r-metHuSCF and Filgrastim;   Drug: r-metHuSCF and Filgrastim;   Drug: Chemotherapy plus Filgrastim
    Sponsors:   Aalborg Hospital;   Herlev Hospital;   Rigshospitalet, Denmark;   Helsinki University Central Hospital;   Turku University Hospital;   University Hospital, Linkoeping;   Umeå University;   Radiumhospitalet Oslo Norway;   Nordic Lymphoma Group;   Amgen
    Suspended - verified November 2009
  • Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants

    Condition:   Rheumatoid Arthritis
    Intervention:   Drug: Etanercept
    Sponsors:   University of Pittsburgh;   Amgen
    Recruiting - verified November 2009
  • Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

    Condition:   Thrombopenia
    Intervention:  
    Sponsors:   Henri Mondor University Hospital;   Amgen Laboratory Inc., France;   Paris 12 University, France
    Completed - verified November 2009
  • ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer

    Condition:   Metastatic Colorectal Cancer
    Interventions:   Drug: Cetuximab (Erbitux);   Drug: Panitumumab (Vectibix)
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009
  • Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

    Condition:   Multiple Myeloma
    Intervention:   Drug: Lenalidomide, Bendamustine, Prednisone
    Sponsors:   University of Leipzig;   Celgene Corporation;   Mundipharma K.K.;   Amgen
    Recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials